Home/ Supplements/ Ginkgo/ Ginkgo Biloba Plus

Ginkgo Biloba Plus

product on market Capsule GNC Herbal Plus Standardized Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Ginkgo biloba and eleuthero are studied for cognitive support and stress adaptation, though evidence for these effects is generally moderate. Yerba mate provides caffeine for alertness, while lecithin supports cellular membrane integrity. Overall, research coverage for this specific combination of ingredients remains limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Ginkgo Biloba Plus
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Botanical
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Eleuthero
150 mg
Yerba Mate leaf extract
100 mg
Market median: 120.0mg (440 products) 191 studies (A:1, B:71)
Lecithin
50 mg

Other Ingredients

Vegetable Cellulose Capsule Cellulose
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take one to two capsules daily.

Warnings & Precautions

CONTAINS: Soybeans.

KEEP OUT OF REACH OF CHILDREN.

WARNING: Consult your physician prior to using this product if you are pregnant, nursing, taking medication, or have a medical condition. Discontinue use two weeks prior to surgery.

Formulation Notes

Standardized Extract Blend

Additional Information

Store in a cool, dry place.

CODE 184501 HLG

May Support Mental Sharpness*

Potency of Flavonglycosides verified by GNC procedure #5000. Conforms to USP <2091> for weight. Meets USP <2040> disintegration.

Metadata

Product Details

UPC / SKU0 48107 09811 7
DSLD Entry Date2011-10-26
Product TypeBotanical
FormCapsule
DSLD ID833
Data Updated2026-04-11
Research

Research Evidence

183
Research Sources
55
Avg Quality
86
Systematic Review
78
Meta Analysis
7
Other
4
Clinical Trial
2
Rct
2
Narrative Review
2
Regulatory Source
1
Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008 PubMed DOI
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020 PubMed DOI
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Ginkgo →
Compare

Similar Products

View all Ginkgo products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.